Last reviewed · How we verify
NCT07024004
Active Exergames Program in Older Adults at Risk of Falls
NA trial testing Exergame-Based Exercise + Conventional Physical Therapy in Risk of Falls in 52 participants. Participants enrolled and being followed up; not accepting new ones.
1 July 2025
Quick facts
| Lead sponsor | Universidad Catolica Silva Henriquez |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 52 |
| Start date | 1 April 2025 |
| Primary completion | 1 July 2025 |
| Estimated completion | 1 October 2025 |
| Sites | 1 location across Chile |
Drugs / interventions tested
- Exergame-Based Exercise + Conventional Physical Therapy
- Conventional Physical Therapy
Conditions studied
- Risk of Falls — all drugs for Risk of Falls →
Sponsor
Universidad Catolica Silva Henriquez
Who can join
60 and older, any sex, with Risk of Falls. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized clinical trial is to analyze the effectiveness of a physical exercise program based on exergames combined with conventional physical therapy, compared to a conventional physical exercise program alone, in improving lower limb strength, muscle quality, and physical capacity in older adults at risk of falling. The main questions it aims to answer are: Does a combined exergame and conventional exercise program improve functional capacity in older adults at risk of falling more than traditional exercise alone? Does the intervention improve lower limb strength and muscle quality more effectively than conventional exercise alone? Researchers will compare a group receiving exergame-based exercise combined with conventional therapy to a group receiving conventional physical exercise only to see if the addition of exergames enhances functional outcomes and muscle performance. Participants will: * Undergo baseline and post-intervention assessments of lower limb strength, muscle quality, and physical capacity. * Participate in a structured physical exercise program. * In the intervention group, perform exergame-based exercises using virtual reality gaming systems such as Nintendo Switch (Ring Fit Adventure). * Engage in sessions for several weeks, with consistent frequency and intensity depending on the group allocation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
E-ACTIVE AGING study protocol: Evaluating an exergame-based and multicomponent exercise program for community-dwelling older adults at risk of falling.
Lillo-Urzúa P, Ugarte-Llanten J, Carreño-Zilmann G, Vidal-Seguel N, et al · · 2025 · PMID 41415308 · DOI 10.3389/fphys.2025.1691454
Verify or expand the search:
- PubMed search for NCT07024004
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universidad Catolica Silva Henriquez trials
Trials by the same sponsor.
- NCT06903455 — A Culturally Significant Cardiovascular Dance-based Intervention in Obese Women · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07024004 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Catolica Silva Henriquez
- Last refreshed: 17 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07024004.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing